DOW:IGWall Street Cash ($10) Analysis
Data as of 2026-05-18 - not real-time
$38.56
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Dow Inc. is trading at $38.56, just below its 20‑day SMA (38.90) but comfortably above the 200‑day SMA (28.40), indicating a short‑term pullback within a longer‑term uptrend. The RSI sits near the midpoint at 49.6, suggesting neither overbought nor oversold conditions, while the MACD histogram is negative and the signal line is bearish, warning of potential downside momentum. Price action is bounded by a clear support at $36.72 and resistance near $41.47, and volume has been trending lower, which could exacerbate price swings in this high‑volatility environment (30‑day volatility > 53%).
Fundamentally, the company posted a Q1 loss despite beating revenue estimates, carries a heavy debt load (Debt/Equity ≈ 117), and generated negative free cash flow, raising concerns about the sustainability of its 3.61% dividend yield. Nevertheless, analysts have upgraded the target to $47, the stock is listed among the best‑performing S&P 500 names in 2026, and a modest upside of ~12% is implied by the current price relative to consensus forecasts.
Fundamentally, the company posted a Q1 loss despite beating revenue estimates, carries a heavy debt load (Debt/Equity ≈ 117), and generated negative free cash flow, raising concerns about the sustainability of its 3.61% dividend yield. Nevertheless, analysts have upgraded the target to $47, the stock is listed among the best‑performing S&P 500 names in 2026, and a modest upside of ~12% is implied by the current price relative to consensus forecasts.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near support with decreasing volume
- Bearish MACD signal
- High short‑term volatility
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Analyst price target uplift to $47
- Bullish longer‑term trend above 200‑day SMA
- Attractive dividend yield if cash flow improves
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Heavy debt burden and negative free cash flow
- Cyclical exposure to chemicals and commodity prices
- Potential geopolitical cost pressures from Strait of Hormuz
Key Metrics & Analysis
Financial Health
Revenue Growth-6.10%
Profit Margin-7.24%
P/E Ratio18.0
ROE-15.26%
ROA-0.14%
Debt/Equity117.13
P/B Ratio1.8
Op. Cash Flow$2.1B
Free Cash Flow$-675875008
Technical Analysis
TrendBullish
RSI49.6
Support$36.72
Resistance$41.47
MA 20$38.90
MA 50$38.56
MA 200$28.40
MACDBearish
VolumeDecreasing
Fear & Greed Index89.61
Valuation
Fair Value$4.79
Target Price$43.06
Upside/Downside11.68%
GradeOvervalued
TypeValue
Dividend Yield3.61%
Risk Assessment
Beta0.61
Volatility53.57%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.